GLP-1 Medications vs Gastric Balloon: Comparing Two Non-Surgical Weight Loss Options

Sarah had been researching weight loss options for months when she stumbled across two very different approaches: her friend lost 42 pounds on semaglutide, while her cousin underwent a gastric balloon procedure. Both claimed theirs was the better choice. Both were non-surgical. Both had impressive before-and-after photos. She felt more confused than ever about which path to take.

You're probably in a similar position. The landscape of non-surgical weight loss has exploded in recent years, giving us more options than ever before. But that abundance of choice comes with its own challenge: how do you actually decide between a weekly injection and a medical device temporarily placed in your stomach? Let's break down what the research actually shows, what you'll experience day-to-day, and which option might align better with your goals and lifestyle.

How Each Option Actually Works in Your Body

GLP-1 medications like semaglutide and tirzepatide work by mimicking a hormone your gut naturally produces after eating. When you inject these medications weekly, they send signals to your brain that you're satisfied, slow down how quickly food leaves your stomach, and help regulate your blood sugar. The effect is gradual but powerful—you'll notice you're thinking about food less, feeling full faster at meals, and not experiencing the same intense cravings that derailed previous weight loss attempts.

The gastric balloon takes a completely different approach. During a brief endoscopic procedure (usually 20-30 minutes), a deflated silicone balloon is placed into your stomach through your mouth, then filled with saline solution. The balloon takes up space—typically about the size of a grapefruit—leaving less room for food. You physically can't eat as much without feeling uncomfortably full.

Here's what's interesting: while both reduce how much you eat, they get there through different mechanisms. GLP-1s change your appetite signals and food reward pathways in your brain. You don't want to eat as much. With a gastric balloon, the desire might still be there, but the physical capacity isn't. You can't eat as much, whether you want to or not.

The balloon stays in place for six months, then must be removed through another endoscopic procedure. During those six months, it's doing its job 24/7—there's no weekly injection to remember, no prescription to refill. But once it comes out, that physical restriction disappears. GLP-1 medications, on the other hand, work as long as you're taking them. Stop the injections, and most people gradually regain weight as their appetite signals return to baseline.

We see this frequently in our patients: the psychological experience differs significantly between these approaches. Some people find the medication approach feels more natural—they're just less hungry. Others appreciate the concrete physical reminder of the balloon, which makes portion control almost automatic. There's no universally "better" mechanism here; it's about which aligns with how you think about food and change.

What the Research Shows About Weight Loss Results

Let's talk numbers, because they're honestly pretty impressive for both options. The STEP 1 trial showed that patients on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks. That means someone weighing 250 pounds would typically lose about 37 pounds. The SURMOUNT-1 trial demonstrated even more dramatic results with tirzepatide: participants lost an average of 15-20.9% of their body weight depending on the dose, with the highest dose producing an average loss of 52 pounds for someone starting at 250 pounds.

Gastric balloon studies show somewhat different results. A 2017 meta-analysis published in Obesity Surgery found that patients with fluid-filled balloons lost an average of 13.2% of their total body weight during the six-month placement period. Another large study of the Orbera balloon system showed patients lost an average of 10.2% of their body weight at six months. So for that same 250-pound person, we're looking at roughly 25-33 pounds lost.

But here's where it gets complicated: what happens after? With GLP-1 medications, the research shows people maintain their weight loss as long as they continue the medication. The STEP 1 trial extension data revealed that participants who stopped semaglutide regained about two-thirds of their lost weight within a year. That sounds discouraging until you remember that people with diabetes take metformin indefinitely, and people with high blood pressure take their medication long-term. Treating obesity as a chronic condition requiring ongoing management is becoming the new medical standard.

For gastric balloons, the picture is more variable. Some studies show good maintenance if patients have adopted new eating habits during the six-month placement period. Others show significant regain. A 2018 study in Gastrointestinal Endoscopy found that patients maintained about 25-30% of their balloon-related weight loss at the one-year mark after removal. The key factor? Whether patients received concurrent behavioral counseling and continued those practices after removal.

The SELECT trial, which looked at semaglutide's cardiovascular benefits, revealed something else important: patients maintained an average 10.2% weight loss over four years while staying on the medication. That kind of long-term data simply doesn't exist for gastric balloons because they're designed as a six-month intervention, not a multi-year treatment.

The Day-to-Day Experience: What to Actually Expect

Starting a GLP-1 medication usually involves a gradual dose escalation. You'll begin with a low dose—maybe 0.25 mg of semaglutide—and slowly increase every four weeks. This titration schedule helps minimize side effects, which we'll get to in a moment. Your weekly injection becomes part of your routine, like taking a vitamin or brushing your teeth. Most of our patients do it the same day each week: Sunday evenings are popular, or Monday mornings to start the week fresh.

The first few weeks, you might notice subtle changes—less interest in snacking, feeling satisfied with smaller portions. By week 8-12, most people report significant appetite reduction. Food just doesn't call to them the way it used to. That mid-afternoon vending machine habit? It fades. The late-night kitchen trips? They stop making sense. You're still eating and enjoying food, but the compulsive quality often diminishes.

The gastric balloon experience is more immediate and intense. Right after placement, most patients feel uncomfortably full, even bloated. The first few days to two weeks are typically rough—nausea is common, some people vomit, and you'll be on a liquid diet initially before gradually advancing to soft foods, then regular foods. Your stomach needs time to adjust to this foreign object taking up space.

Once you've adapted (usually by week 3-4), eating becomes a very conscious activity. You'll need to eat slowly, chew thoroughly, and stop at the first sign of fullness—or face uncomfortable consequences like nausea or vomiting. Drinking while eating can cause problems. Carbonated beverages are generally off-limits. You're working with about one-third of your normal stomach capacity, so three small meals and a couple of tiny snacks become your new pattern.

Some patients love this structure. It forces mindfulness around eating in a way nothing else has. Others find it restrictive and frustrating, especially in social situations. Imagine going to a restaurant and being able to eat only a few bites before you're physically done. For six months, that's your reality.

Side Effects, Risks, and What Could Go Wrong

GLP-1 medications are generally well-tolerated, but they're not side-effect-free. The most common complaints are gastrointestinal: nausea affects about 20-40% of people (though usually mild and improving over time), occasional vomiting, diarrhea, and constipation. Some patients experience heartburn or acid reflux. These effects typically peak when you increase your dose and then settle down.

Less common but worth knowing about: there's a small risk of pancreatitis, gallstones (usually related to rapid weight loss itself), and potential thyroid concerns that showed up in rodent studies but haven't been confirmed in humans. That's why patients with a personal or family history of medullary thyroid cancer shouldn't use these medications. The fatigue some people report in the first few weeks usually resolves as your body adjusts.

Gastric balloon risks fall into a different category. The placement and removal procedures carry the risks associated with any endoscopy—though serious complications are rare. During the six months the balloon is in place, about 10-12% of patients experience persistent nausea and vomiting severe enough to require early removal. Balloon deflation happens in roughly 1-3% of cases; if the balloon deflates, it could potentially cause bowel obstruction, requiring emergency removal.

Other balloon-related issues include gastric ulcers (occurring in about 4-8% of patients), balloon migration, and in very rare cases, gastric perforation. The first few weeks are when most people feel the worst—that adjustment period can be genuinely miserable for some patients. Unlike a medication you can just stop taking, removing the balloon requires another procedure.

Death is extraordinarily rare with either option, but has been reported with gastric balloons (usually related to gastric perforation or aspiration). With GLP-1s, the medication is out of your system within weeks if you need to stop. With a balloon, you're committed for either six months or until the discomfort becomes severe enough to justify the removal procedure.

From the Ozari Care Team

We've worked with hundreds of patients navigating this exact decision, and here's what we tell them: think about your relationship with food and your capacity for long-term commitment. If the idea of a daily or weekly medication feels manageable and you want gradual change that you control, GLP-1s often provide better flexibility. If you're looking for a defined six-month intervention that forces immediate behavior change and you're ready for an intense adjustment period, a balloon might appeal to you. We also find that patients who've struggled with portion control specifically—not just cravings or food thoughts—sometimes gravitate toward the balloon's physical restriction. But most of our patients appreciate that GLP-1 therapy addresses the hormonal and neurological aspects of appetite, which feels more sustainable long-term.

Key Takeaways

• GLP-1 medications produced 15-21% average weight loss in major trials (STEP 1, SURMOUNT-1), while gastric balloons typically result in 10-13% loss during the six-month placement period
• GLP-1s work by changing appetite signals in your brain and require ongoing use; gastric balloons physically restrict stomach capacity for six months, then are removed
• Side effects differ significantly: GLP-1s mainly cause manageable nausea and GI symptoms, while balloons involve an intense 2-4 week adjustment period with potential for persistent nausea requiring early removal in 10-12% of cases
• Long-term data strongly favors GLP-1s, with studies showing maintained weight loss over 4+ years on medication, while balloon results after removal are highly variable and depend on behavior changes
• Cost considerations matter: GLP-1s range from $99-1,300+ monthly depending on your source, while gastric balloons typically cost $6,000-9,000 out-of-pocket for the six-month program

Frequently Asked Questions

Can I do both a gastric balloon and GLP-1 medication at the same time?

Some bariatric centers are actually exploring this combination approach, though it's not yet standard practice. The theoretical advantage is that you'd get both the physical restriction from the balloon and the appetite-suppressing effects of the GLP-1, potentially producing better results than either alone. However, combining them also means potentially compounding side effects—nausea from both interventions could be really challenging. There's limited research on this combination, so most providers recommend choosing one approach first and evaluating results before considering adding another intervention.

Which option is better if I've already tried and failed with diet and exercise multiple times?

Here's the thing: both options work best alongside lifestyle changes, not instead of them. That said, GLP-1 medications often feel like a revelation to people who've struggled with constant hunger and food preoccupation despite their best efforts—suddenly willpower isn't the entire equation. The medication addresses the biological drivers that made previous attempts so difficult. A gastric balloon forces portion control but doesn't change the underlying appetite signals, so you'll need strong behavioral support to make changes stick beyond the six-month placement. In our clinical experience, patients who describe themselves as "always thinking about food" often respond particularly well to GLP-1s because that mental chatter quiets down significantly.

Will my insurance cover either of these options?

Insurance coverage varies wildly. Some plans cover GLP-1 medications for weight loss (especially if you have diabetes or prediabetes), while others explicitly exclude weight management medications. Gastric balloons are considered less invasive than surgery, and many insurance plans don't cover them, classifying them as cosmetic or experimental—expect to pay $6,000-9,000 out-of-pocket. Before the approval of compounded versions, brand-name GLP-1s cost $1,000-1,300 monthly without insurance, but compounded semaglutide and tirzepatide are now available for as low as $99/month through specialized telehealth providers. Always check your specific plan's formulary and prior authorization requirements, and don't hesitate to appeal denials with documentation from your provider about medical necessity.

What happens to loose skin with these two approaches?

Loose skin depends more on how much weight you lose, how quickly, your age, genetics, and skin elasticity than on which method you use to lose the weight. That said, GLP-1 medications typically produce more gradual weight loss over 12-18 months, which may give your skin more time to adapt compared to the rapid loss some people experience with a gastric balloon over six months. Neither approach prevents loose skin if you're losing a substantial amount of weight (50+ pounds). Strength training during weight loss, staying hydrated, and maintaining adequate protein intake can help somewhat, but if significant loose skin develops, it won't resolve on its own—that would require surgical intervention regardless of how you lost the weight.

Can I drink alcohol with a gastric balloon or on GLP-1 medications?

With a gastric balloon, alcohol is generally discouraged, especially carbonated alcoholic beverages like beer or champagne. Your reduced stomach capacity means alcohol gets absorbed more quickly, and you may feel intoxicated faster and more intensely than before. Plus, alcohol's empty calories can undermine your weight loss efforts when you have so little room for food. On GLP-1 medications, many patients report a naturally decreased interest in alcohol—it just doesn't appeal the same way. There's no absolute prohibition, but the medications slow gastric emptying, which can also intensify alcohol's effects. Moderation becomes even more important, and you should discuss your specific situation with your provider, especially if you're taking other medications or have liver concerns.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.